Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Height Influence the Effectiveness of Beta-Blocker Therapy after Myocardial Infarction?

Cardiology·2026
Same author

Investigation of Possible Cardiac Manifestations of Dysautonomia in a Patient With Acquired Ondine's Curse Syndrome: A Rare Clinical Case Report.

Cureus·2026
Same author

Editorial: Epicardial-only left atrial appendage closure: Insights from seven years of first-in-human experience.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Editorial: Do we still need routine pre-discharge echocardiography after LAAC?

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Worsening Hiccups, Dyspnea, and Angina in a 67-Year-Old Woman: A Challenging Case.

Cureus·2025

Related Experiment Video

Updated: May 13, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Carotid artery stenting update.

Mehmet Cilingiroglu1, Konstantinos Marmagkiolis, Mark H Wholey

  • 1University of Pittsburgh Medical Center Heart & Vascular Institute, PA, USA.

Future Cardiology
|March 8, 2013
PubMed
Summary
This summary is machine-generated.

Carotid artery stenting is now an equally safe and effective stroke prevention method compared to traditional endarterectomy, especially for high-risk patients. This less invasive option has gained acceptance due to improved technology and patient preference.

Related Experiment Videos

Last Updated: May 13, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

  • Neurology
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Stroke is a leading cause of death and disability in the USA.
  • Carotid artery disease accounts for approximately 25% of all strokes.
  • Endarterectomy is the current standard treatment for significant carotid artery disease.

Purpose of the Study:

  • To compare the safety and efficacy of carotid artery stenting (CAS) versus carotid endarterectomy (CEA).
  • To evaluate CAS as an alternative stroke prevention strategy.
  • To assess the role of CAS in high-risk patient populations.

Main Methods:

  • Review of clinical trials including SAPPHIRE and CREST, comparing CAS and CEA.
  • Analysis of procedural outcomes, including death, stroke, and myocardial infarction.
  • Consideration of technological advancements and patient demand.

Main Results:

  • The SAPPHIRE trial demonstrated noninferiority of CAS to CEA in high-risk patients.
  • The CREST trial showed no significant difference in outcomes between CAS and CEA.
  • Carotid artery stenting is now FDA-approved for high-risk patients.

Conclusions:

  • Carotid artery stenting is an equally efficient and safe procedure for stroke prevention.
  • Advancements in stent technology and embolic protection have improved CAS outcomes.
  • Patient preference for less invasive procedures favors the adoption of CAS.